Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by IainCaimbeulon Jan 30, 2022 6:31pm
101 Views
Post# 34376603

RE:RE:RE:RE:RE:RE:RE:RE:Aristotle appointments gone for this week

RE:RE:RE:RE:RE:RE:RE:RE:Aristotle appointments gone for this weekNo no, not q1. Then it will be, just wait until q2, then q3, them q4. Then 2023 q?...
brad129 wrote:

I think we need to wait until May, March isn't going to show much. The good part of Q4 to Q1 is we only have 45 extra days to wait.


LithLover wrote:

Well than as per IainCaimbeul :  Moderators please close this board until March 31.

Thanks 
 

IainCaimbeul wrote: Tallguy, it wasn't you I was chirping. It was the folks who in their deperation to try and put a positive spin on StageZero's miserable stock price. They resort to posting inane spreadsheets showing vast sums being made (actually made up), fake/test ULR's going nowhere, Fidelity munching, munching,and more munching. Jesus there were days I bought more than Fidelity, stocks and warrents! Following booking appointments, which are just that - booking appointments.

How about financials that are transparent and meaningful. How about questions after a NR?
How about a lot more openness?

Try getting an answer from HR on any important aspect of StageZero operations. No way.

Same old garbage.

For anyone who is a bag holder I feel sorry for you.

Due diligence is virtually impossible when the entity you want to do it on is not forthright.

But the best of all is that I am dumb enough to still be here. Who knows I may still make a pile of money on this gig, although I am prepped for the worst.


 

 

tallguy wrote:
Well, i feel a little irony in your comment, I don't mind, due dilignence is not always bad to do.

 






<< Previous
Bullboard Posts
Next >>